Alimenté par : Claudia (ADFI Alsace)
Cet outil s'appuie sur PubMind
PubMind est une plateforme collaborative de veille scientifique qui permet d'importer des publications depuis PubMed, de suivre leur avancement de lecture, d'en extraire les éléments méthodologiques clés (protocoles, variables, résultats) et de constituer une synthèse structurée afin de faciliter la réalisation de revues de littérature. Entièrement personnalisable, cet outil s'adapte aux thématiques de recherche de ses utilisateurs.
Nous l'avons configuré ici pour centraliser et analyser la littérature scientifique concernant les croyances, les traitements psychologiques, l'étude de la scrupulosité, ainsi que l'impact et la prise en charge des troubles liés aux dérives sectaires.
Dernière synchronisation le 05/06/2026
J Nerv Ment Dis . 2019;207 (6) :515-522
We examined and compared the relationship between religiosity and symptom severity in patients with major depressive disorder (MDD) rated by the Hamilton Depression Rating Scale) and schizophrenia (rated by the Positive and Negative Syndrome Scale). The Duke University Religion Index, the Santa Clara Strength of Religious Faith (SCSORF) questionnaire, and the Brief Religious Coping scale scores were similar between patients with MDD (n = 50) and patients with schizophrenia (n = 50). In patients with MDD, higher organizational religious activity (ORA) (estimate = 2.28, 95% confidence interval [CI] = 0.37-4.19; p = 0.020) and higher negative religious coping (estimate = 0.43, 95% CI = 0.03-0.84; p = 0.037) were independently associated with more severe symptoms. In patients with schizophrenia, higher ORA was associated with lower negative symptoms (estimate = -1.99, 95% CI = -3.94 to -0.03; p = 0.046). Higher SCSORF was associated with lower ORA in both patient subsets, and thus indirectly with milder symptoms in patients with MDD and with more severe negative symptoms in patients with schizophrenia. The relationship between religiosity and symptom severity apparently differs in patients with MDD and those with schizophrenia.